CASALUDMIDO Insulin Resistance |
The strategy Integrated Measurement for Early Detection (MIDO), offers a new possibility to detect insulin resistance levels in pre-diabetes patients. Dr. Hector Gallardo, Operational Solutions Director at the Carlos Slim Health Institute, explains this important development achieved in the CSHI, in alliance with scientists from North Carolina USA.
- Awareness, Early Detection and Fighting Prejudice, Keys in the Fight against Breast Cancer (External link in Spanish)
- Digital Portfolio
- Diploma in Non-transmissible Chronic Diseases Comprehensive Care and Prevention (External link in Spanish)
- Innovative Technologies
- MIDO Insulin Resistance
- Physical Activity and Sedentary Lifestyle II, with Dr. John Duperly
- Human Capital
- Physical Activity and Sedentary Lifestyle I, with Dr. John Duperly
- Innovation in Primary Prevention: Development of Preventive Cardiovascular Polypill
